Pathstone Family Office’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $895K | Buy |
3,696
+554
| +18% | +$134K | 0.01% | 762 |
|
|
2023
Q2 | $755K | Buy |
+3,142
| New | +$755K | 0.01% | 575 |
|
|
2023
Q1 | – | Sell |
-5,598
| Closed | -$990K | – | 1375 |
|
|
2022
Q4 | $990K | Buy |
5,598
+286
| +5% | +$50.6K | 0.01% | 799 |
|
|
2022
Q3 | $836K | Buy |
+5,312
| New | +$836K | 0.01% | 835 |
|
|
2021
Q1 | – | Sell |
-6
| Closed | -$1K | – | 1043 |
|
|
2020
Q4 | $1K | Hold |
6
| – | – | ﹤0.01% | 1076 |
|
|
2020
Q3 | $1K | Sell |
6
-6
| -50% | -$1K | ﹤0.01% | 751 |
|
|
2020
Q2 | $2K | Buy |
+12
| New | +$2K | ﹤0.01% | 635 |
|